Ace the 2025 AANP Adult-Gerontology Primary Care NP Exam – Your Path to Nurse Practitioner Stardom!

Salmeterol is recognized as a long-acting beta agonist (LABA) that is commonly employed in the management of chronic obstructive pulmonary disease (COPD). LABAs are designed to provide prolonged bronchodilation effects, typically lasting for 12 hours or more. This makes them particularly beneficial for patients who need long-term control of their respiratory symptoms.

In the context of COPD, salmeterol acts by relaxing the muscles in the airways, which helps to alleviate symptoms such as wheezing, breathlessness, and tightness in the chest. Its extended duration of action means that it can be administered twice daily, allowing for better adherence to treatment and improved overall management of the disease.

Other medications listed in the question serve different roles. Ipratropium, which is a short-acting anticholinergic agent, is used for acute symptom relief but does not provide the long-acting benefits of a LABA. Albuterol is a short-acting beta agonist and is typically used for quick relief of acute symptoms rather than for long-term management. Fluticasone is an inhaled corticosteroid that helps reduce inflammation but does not have the bronchodilation properties characteristic of a LABA.

Overall, salmeterol